相关实验视频
Updated: May 7, 2025

FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
常规产前cfDNA查自体主导单基因疾病
Sophie Adams1, Olivia Maher Trocki1, Christina Miller1
1Center for Fetal Medicine and Reproductive Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
针对单基因疾病的常规无细胞DNA查 (cfDNA-SGD) 在0.51%的怀孕中发现了高风险结果. 这使得早期干预成为可能,但由于变体的分类和表达性,这给辅导带来了挑战.
科学领域:
- 遗传学 是一个遗传学.
- 生殖医学 生殖医学
- 分子诊断学 分子诊断
背景情况:
- 遗传查已经从检测形体变形症演变为单基因疾病 (cfDNA-SGD).
- 对cfDNA-SGD的临床验证在高风险怀孕中是有希望的,但在一般人群中研究较少.
研究的目的:
- 在一般孕妇群体中评估单基因疾病 (cfDNA-SGD) 常规无细胞DNA查的实用性和结果.
- 评估cfDNA-SGD结果的一致性和临床意义.
主要方法:
- 对于25种自身主导性疾病进行cfDNA-SGD查的怀孕的回顾性图表审查.
- 排除具有超声波异常或已知的家族病史的怀孕.
- 查一致性,妊娠结果和表型的分析.
主要成果:
- 9.4%的孕妇接受了cfDNA-SGD查,其中78.9%是例行检查.
- 常规查的0.51%产生了高风险结果 (致病性/可能致病性变体).
- 诊断测试证实了11/14名受影响怀孕/新生儿的变异,没有假阳性,但有两个不一致的分类.
结论:
- 常规cfDNA-SGD查发现0.51%的怀孕是高风险的,需要进一步评估.
- 通过cfDNA-SGD进行早期识别,可以及时进行干预.
- 挑战包括由于可变表现力的辅导,有限的基因型-表型相关性和分类差异的辅导.
更多相关视频
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
相关概念视频
Pedigree Analysis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Karyotyping
Animal Mitochondrial Genetics
Incomplete Dominance